Terra Reynolds > Latham & Watkins LLP > Houston, United States > Lawyer Profile

The team at Latham & Watkins LLP handles a growing number of disputes concerning pandemic and telemedicine-related fraud. John Manthei, Ben Haas, and Jason Caron co-lead the team from Washington DC. California’s Jason Ohta focuses on white-collar criminal defence work, regularly appearing before the Ninth Circuit Court of Appeals, while Terra Reynolds represents clients in cases concerning allegations of healthcare fraud and abuse in Illinois. In Washington DC, Jason Caron is well versed in mandates concerning coverage, including surprise billing and medical necessity, while Eric Greig is noted for his regulatory expertise, particularly in relation to Medicare billing policy compliance and Sunshine laws on both a state and federal level. Working out of the Boston office, David Tolley regularly acts for hospital systems on FCA and Anti-Kickback related issues, in addition to a range of government investigations.

Latham & Watkins LLP works with a number of major players in the life sciences industry on transactions in the sector, handling both M&A and IPOs, in addition to assisting with business combinations and licensing deals. In addition to transactional expertise, the practice is adept at overseeing patent protection strategies and litigation for pharma, biotech and medical devices companies. In Washington DC, John Manthei chairs the firm’s global life sciences group, specializing in the FDA regulatory process alongside vice chair Ben Haas, while also advising on the marketing of drugs and representing clients in Administrative Procedures Act litigation. Further litigation expertise comes in the shape of New York’s Arlene Chow and Chicago-based Terra Reynolds, with the former handling patent disputes concerning small molecule drugs and biologics, and the latter focusing on white collar defence and government investigations. In Silicon Valley, Shayne Kennedy is noted for his capital markets practice, advising on public and private securities offerings by life sciences clients. Boston’s Julie Scallen oversees both M&A and private equity transactions, and Elizabeth Richards, William McConagha and Jennifer Bragg, based in the capital, assist with FDA and DEA product testing and approval procedures. Judith Hasko has left the firm.

Latham & Watkins LLP continues to be a market-leading firm in the area of white-collar investigations, with a strong team in Washington DC, which includes Alice S. Fisher, Douglas Greenburg, and Kevin Andrew Chambers. Greenburg is particularly skilled at representing prominent companies embroiled in cross-border investigations, while Chambers is recommended for his capabilities with handling internal investigations and government inquiries. Fisher has experience advising on a variety of white-collar matters, including health care fraud, FCPA offences, and sanction violations. Benjamin Naftalis and Doug Yatter are based in New York. Naftalis represents a wide range of clients facing enforcement action by regulatory authorities such as boards of directors, senior executives, and corporations. With his in-depth understanding of digital assets and financial regulations, Yatter is recommended for banks, cryptocurrency founders, and fintech institutions being investigated by the SEC, DOJ, and CFTC. Terra Reynolds practices in Chicago; she focusses on false claims and anti-kickback matters within the healthcare industry.